PepT1 expressed in immune cells has an important role in promoting the immune response during experimentally induced colitis

Laboratory Investigation

Volumn 93, Issue 8, 2013, Pages 888-899

  Ayyadurai, Saravanan ^a   Charania, Moiz A ^a   Xiao, Bo ^a   Viennois, Emilie ^a   Merlin, Didier ^a,b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Inflammation; PepT1 KO; siRNA

Indexed keywords

CXCL1 CHEMOKINE; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 6; LEUCINE RICH REPEAT KINASE 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MURAMYL DIPEPTIDE; MYELOPEROXIDASE; PEPTIDE TRANSPORTER 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARCHITECTURE; ARTICLE; CELL DISRUPTION; CHEMOTAXIS; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; DIARRHEA; DISEASE SEVERITY; ENTERITIS; ENZYME ACTIVITY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INTESTINE FLORA; KNOCKOUT MOUSE; LAMINA PROPRIA; LARGE INTESTINE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RECTUM HEMORRHAGE; RNA EXTRACTION; SMALL INTESTINE; WEIGHT REDUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HOMEOSTASIS; IMMUNITY, CELLULAR; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEROXIDASE; RNA, MESSENGER; SYMPORTERS;

EID: 84881037638     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.77     Document Type: Article

References (56)

1. Adibi SA. Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorption. J Clin Invest 1971;50: 2266-2275.
2. Mathews DM, Adibi SA. Peptide absorption. Gastroenterology 1976; 71: 151-161.
3. Adibi SA. Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am J Physiol Gastrointest Liver Physiol 2003;285: G779-G788.
4. Fei YJ, Kanai Y, Nussberger S, et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 1994;368: 563-566.
5. Liang R, Fei YJ, Prasad PD, et al. Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem 1995;270: 6456-6463.
6. Bretschneider B, Brandsch M, Neubert R. Intestinal transport of betalactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm Res 1999;16: 55-61.
7. Brodin B, Nielsen CU, Steffansen B, et al. Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1. Pharmacol Toxicol 2002;90: 285-296.
8. de Vrueh RL, Smith PL, Lee CP. Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2. J Pharmacol Exp Ther 1998;286: 1166-1170.
9. Friedman DI, Amidon GL. Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysylproline type: lisinopril and SQ 29,852. J Pharm Sci 1989;78: 995-998.
10. Kramer W, Girbig F, Gutjahr U, et al. Interaction of renin inhibitors with the intestinal uptake system for oligopeptides and beta-lactam antibiotics. Biochim Biophys Acta 1990;1027: 25-30.
11. Nielsen CU, Supuran CT, Scozzafava A, et al. Transport characteristics of L-carnosine and the anticancer derivative 4-toluenesulfonylureidocarnosine in a human epithelial cell line. Pharm Res 2002;19: 1337-1344.
12. Daniel H. Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol 2004;66: 361-384.
13. Merlin D, Steel A, Gewirtz AT, et al. hPepT1-mediated epithelial transport of bacteria-derived chemotactic peptides enhances neutrophil- epithelial interactions. J Clin Invest 1998;102: 2011-2018.
14. Buyse M, Charrier L, Sitaraman S, et al. Interferon-gamma increases hPepT1-mediated uptake of di-tripeptides including the bacterial tripeptide fMLP in polarized intestinal epithelia. Am J Pathol 2003;163: 1969-1977.
15. Vavricka SR, Musch MW, Chang JE, et al. hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology 2004;127: 1401-1409.
16. Dalmasso G, Nguyen HT, Charrier-Hisamuddin L, et al. PepT1 mediates transport of the proinflammatory bacterial tripeptide L-Ala-{gamma}- D-Glu-meso-DAP in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2010;299: G687-G696.
17. Merlin D, Si-Tahar M, Sitaraman SV, et al. Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules. Gastroenterology 2001;120: 1666-1679.
18. Nguyen HT, Dalmasso G, Powell KR, et al. Pathogenic bacteria induce colonic PepT1 expression: an implication in host defense response. Gastroenterology 2009;137: 1435-47, e1-2.
19. Nduati V, Yan Y, Dalmasso G, et al. Leptin transcriptionally enhances peptide transporter (hPepT1) expression and activity via the cAMPresponse element-binding protein and Cdx2 transcription factors. J Biol Chem 2007;282: 1359-1373.
20. Charrier L, Merlin D. The oligopeptide transporter hPepT1: gateway to the innate immune response. Lab Invest 2006;86: 538-546.
21. Smith PD, Smythies LE, Mosteller-Barnum M, et al. Intestinal macrophages lack CD14 and CD89 and consequently are downregulated for LPS- and IgA-mediated activities. J Immunol 2001;167: 2651-2656.
22. Smythies LE, Sellers M, Clements RH, et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005;115: 66-75.
23. Buyse M, Tsocas A, Walker F, et al. PepT1-mediated fMLP transport induces intestinal inflammation in vivo. Am J Physiol Cell Physiol 2002;283: C1795-C1800.
24. Chiu NM, Chun T, Fay M, et al. The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides. J Exp Med 1999; 190: 423-434.
25. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol 2002;23: 541-548.
26. Eckmann L. Innate immunity and mucosal bacterial interactions in the intestine. Curr Opin Gastroenterol 2004;20: 82-88.
27. Eckmann L. Sensor molecules in intestinal innate immunity against bacterial infections. Curr Opin Gastroenterol 2006;22: 95-101.
28. Philpott DJ, Girardin SE. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 2004;41: 1099-1108.
29. Ku CL, Yang K, Bustamante J, et al. Inherited disorders of human Tolllike receptor signaling: immunological implications. Immunol Rev 2005;203: 10-20.
30. Chamaillard M, Girardin SE, Viala J, et al. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 2003;5: 581-592.
31. Barnich N, Aguirre JE, Reinecker HC, et al. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J Cell Biol 2005;170: 21-26.
32. Inohara Chamaillard, McDonald C, Nunez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Ann RevBiochem 2005;74: 355-383.
33. Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat RevImmunol 2003;3: 371-382.
34. Murillo LS, Morre SA, Pena AS. Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response. Drugs Today 2003;39: 415-438.
35. Strober W, Murray PJ, Kitani A, et al. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006; 6: 9-20.
36. Tanabe T, Chamaillard M, Ogura Y, et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 2004;23: 1587-1597.
37. Viala J, Sansonetti P, Philpott DJ. Nods and 'intracellular' innate immunity. C R Biol 2004;327: 551-555.
38. Dalmasso G, Nguyen HT, Ingersoll SA, et al. The PepT1-NOD2 signaling pathway aggravates induced colitis in mice. Gastroenterology 2011; 141: 1334-1345.
39. Laroui H, Yan Y, Narui Y, et al. L-Ala-gamma-D-Glu-meso-diaminopimelic acid (DAP) interacts directly with leucine-rich region domain of nucleotide-binding oligomerization domain 1, increasing phosphorylation activity of receptor-interacting serine/threonine-protein kinase 2 and its interaction with nucleotide-binding oligomerization domain 1. J Biol Chem 2011;286: 31003-31013.
40. Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69: 238-249.
41. Charania MA, Ayyadurai S, Ingersoll SA, et al. Intestinal epithelial CD98 synthesis specifically modulates expression of colonic microRNAs during colitis. Am J Physiol Gastrointest Liver Physiol 2012;302: G1282-G1291.
42. Charania MA, Laroui H, Liu H, et al. Intestinal epithelial CD98 directly modulates the innate host response to enteric bacterial pathogens. Infect Immun 2013;81: 923-934.
43. Weigmann B, Tubbe I, Seidel D, et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc 2007;2: 2307-2311.
44. Aksamit RR, Falk W, Leonard EJ. Chemotaxis by mouse macrophage cell lines. J Immunol 1981;126: 2194-2199.
45. Garrett WS, Lord GM, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007;131: 33-45.
46. Fagarasan S, Muramatsu M, Suzuki K, et al. Critical roles of activationinduced cytidine deaminase in the homeostasis of gut flora. Science 2002;298: 1424-1427.
47. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118: 229-241.
48. Charrier L, Driss A, Yan Y, et al. hPepT1 mediates bacterial tripeptide fMLP uptake in human monocytes. Lab Invest 2006;86: 490-503.
49. Wojtal KA, Eloranta JJ, Hruz P, et al. Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metab Dispos 2009;37: 1871-1877.
50. Zucchelli M, Torkvist L, Bresso F, et al. PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease. Inflamm Bowel Dis 2009;15: 1562-1569.
51. Yang B, Smith D. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice. Drug Metab Dispos 2013;41: 608-614.
52. Chen HQ, Shen TY, Zhou YK, et al. Lactobacillus plantarum consumption increases PepT1-mediated amino acid absorption by enhancing protein kinase C activity in spontaneously colitic mice. J Nutr 2010;140: 2201-2206.
53. Chen HQ, Yang J, Zhang M, et al. Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice. Am J Physiol Gastrointest Liver Physiol 2010;299: G1287-G1297.
54. Hu Y, Smith DE, Ma K, et al. Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine. Mol Pharm 2008;5: 1122-1130.
55. Yang XD, Ma JY, Barger MW, et al. Transport and utilization of arginine and arginine-containing peptides by rat alveolar macrophages. Pharm Res 2002;19: 825-831.
56. Zaki MH, Lamkanfi M, Kanneganti TD. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol 2011;32: 171-179.